The study is planned to show whether combined hypolipemic and antidiabetic therapy with various daily dosages influence the fasting plasma glucose, insulin sensitivity and proinflammatory cytokines in diabetic and dyslipidemic subjects.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
200
Patient will take three pill consisting of metformin 1000mg, simvastatin 10mg and fenofibrate 100mg.
Department of Clinical Pharmacology
Katowice, Katowice, Poland
Antiinflammatory effects of combined antidiabetic and hypolipemic treatment
As inflammatory effects we measure the difference in serum concentration before and after the treatment of the following proinflammatory cytokines: 1. Interleukin 1 2. TNF alpha 3. Interleukin 6 4. Interleukin 10 5. hsCRP
Time frame: 30 days
Insulin sensitivity
Assesed by HOMA (Homeostatic Model of Assessment)
Time frame: 30 days
Coagulation parameters
Assessed using: 1. Fibrinogen 2. PAI-1
Time frame: 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.